population, is to convey the opinion that such disproportional representation is not fair and does not make the most of the diversity available, while bordering on racist inclinations and gender inequality, as well.
It also attempts to put forth a convincing argument, with evidences, to uphold the fact that inclusion of the blacks, as well as, the female population would certainly lead to a better prospect for the industry, since to throws up lurking talent, while also paving way for a more balanced research. This not only wipes out grievances that exist in the non-represented part of the population, but also promotes equality and brotherhood.
Clinical research is a particularly difficult topic. In most research communities industrial and federal agencies have been, for more than a decade, refusing to obtain information about inconsistent drug effects on patients based on race, ethnicity, gender and age. I will discuss the model development, study design in relate to clinical trials. Also I will talk about the participant factors in general and my personal factors. The last point I will be discussing is the ethnically diverse patients.
SELECTION OF SUBJECTS
The ideal path towards success for any industry, is to make the most out of the man power and talent pool available. Under such circumstances, the selection of candidates is a crucial phase. Priority attached to a particular strata or section of the society, while leaving out the others, is often dangerous as it paves way for inequality and further, it does not recognise the talent of the rest of the masses.
Our core industry and area in this article, is that of the U.S. clinical research, wherein majority of the individuals enrolled for the research are white males. The very mention of 'white males' highlights the fact that two important sections of the society---the females and the blacks are not very prominently represented in the enrolment.
In the Model Development the proposed Model for Clinical Trial Participation was developed based on a literature review and experiences with subject participation. Analysis and use of the model in implementation of clinical trials may be helpful in all research disciplines. The model identifies barriers and issues related to clinical trial participation, strategies that can be used for success, and outcomes for successful clinical trials.
A literature review indicated that successful clinical trials depend on certain key issues and factors: study design, participant factors, issues related to ethnic diversity, the informed consent process, and physician factors. Strategies for success are identified in the model to overcome these issues and concerns, and specific outcomes are identified. Healthcare providers across disciplines can use the model prior to and during enrolment of patients into studies. A literature review revealed specific barriers and factors related to the success of clinical trials. The major barriers identified were study design, participant factors (i.e., general and personal issues related to special populations), the